By Dan Darrow
October 20, 2022
Intraday Update: MDGL
Today is the decision day for the MDGL Nov18 strangle, and after monitoring the options for a couple of weeks, we are going to need to walk away from the trade idea. The option pricing is not lining up for a quality risk/reward setup, and opening a higher-risk position with a subpar risk/reward does not make sense. It's frustrating to not participate on this catalyst, but there will be other Biotech data events to play.
Trader Author Portfolio Holdings
**As of the date and time of publication